(S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic acid
CAS: 81677-64-7
Ref. 3D-FB19182
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
- N,N'-[(1S)-1-[[4-[(Bromoacetyl)amino]phenyl]methyl]-1,2-ethanediyl]bis[N-(carboxymethyl)-glycineBABE
- Glycine, N,N′-[(1S)-1-[[4-[(bromoacetyl)amino]phenyl]methyl]-1,2-ethanediyl]bis[N-(carboxymethyl)-
- N,N′-[(1S)-1-[[4-[(2-Bromoacetyl)amino]phenyl]methyl]-1,2-ethanediyl]bis[N-(carboxymethyl)glycine]
- BABE
- Glycine, N,N′-[1-[[4-[(bromoacetyl)amino]phenyl]methyl]-1,2-ethanediyl]bis[N-(carboxymethyl)-, (S)-
- Glycine, N,N′-[(1S)-1-[[4-[(2-bromoacetyl)amino]phenyl]methyl]-1,2-ethanediyl]bis[N-(carboxymethyl)-
(S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic acid (BABB) is a DNA transcription activator that is used in the treatment of wastewater. It activates transcription by binding to regulatory proteins and polymerase chain reaction (PCR). The activated form of BABB can be detected using an assay on a carboxy terminal protein. This drug has been found to be effective in treating patients with cancer, as it inhibits the synthesis of DNA and RNA. BABB also has diagnostic properties because it binds to monoclonal antibodies and α subunit sequences.
Propriedades químicas
Consulta técnica sobre: 3D-FB19182 (S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic acid
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
